HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 43.95
+0.30 (0.69%)
Jul 30, 2026, 12:49 PM CST
HeXun Biosciences Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 111.91 | 147.22 | 33.49 | -5.19 | -42.99 |
Depreciation & Amortization | 27.91 | 23.52 | 19.1 | 14.19 | 11.43 |
Other Amortization | 1.04 | 1.2 | 1.2 | 0.53 | 0.48 |
Loss (Gain) From Sale of Assets | 1.62 | 0.01 | 0.05 | -0.02 | -0.2 |
Stock-Based Compensation | 3.62 | - | - | 0.3 | - |
Other Operating Activities | -4.36 | 13.97 | -0.07 | -0.05 | 0.47 |
Change in Accounts Receivable | 10.12 | -62.39 | -17.3 | -4.98 | - |
Change in Inventory | 9.56 | -10.98 | -4.6 | - | - |
Change in Accounts Payable | -1.07 | 1.81 | -0.8 | 0.42 | -4.3 |
Change in Unearned Revenue | 5.26 | 6.97 | -3.37 | 5.1 | - |
Change in Other Net Operating Assets | -1.71 | -0.4 | 15.39 | 0.93 | -0.39 |
Operating Cash Flow | 163.89 | 120.92 | 43.09 | 11.23 | -35.5 |
Operating Cash Flow Growth | 35.54% | 180.62% | 283.77% | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -27.29 | -37.29 | -20.67 | -1.23 | - |
Sale of Property, Plant & Equipment | - | - | - | 0.13 | 8.84 |
Sale (Purchase) of Intangibles | -1.57 | - | -0.64 | -5.96 | - |
Investment in Securities | -129.43 | -100 | - | -72 | - |
Other Investing Activities | -0.09 | - | -3.97 | - | -35.78 |
Investing Cash Flow | -158.38 | -137.29 | -25.28 | -79.05 | -26.95 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | -3.81 | -40.31 | -4.88 | -2.46 | -2.01 |
Net Debt Issued (Repaid) | -3.81 | -40.31 | -4.88 | -2.46 | -2.01 |
Issuance of Common Stock | - | - | 125 | 105 | 78 |
Other Financing Activities | 5.5 | - | - | - | -0.2 |
Financing Cash Flow | 1.69 | -40.31 | 120.12 | 102.54 | 75.79 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 7.21 | -56.68 | 137.93 | 34.72 | 13.34 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 136.61 | 83.63 | 22.42 | 10 | -35.5 |
Free Cash Flow Growth | 63.36% | 272.98% | 124.19% | - | - |
Free Cash Flow Margin | 46.59% | 29.20% | 17.17% | 20.22% | - |
Free Cash Flow Per Share | 2.97 | 1.82 | 0.49 | 0.27 | -1.16 |
Levered Free Cash Flow | 94.91 | 33.7 | 9.68 | 0.46 | - |
Unlevered Free Cash Flow | 95.61 | 34.43 | 10.84 | 1.48 | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1.1 | 1.24 | 1.79 | 1.64 | 1.57 |
Cash Income Tax Paid | 18.33 | 0.17 | - | - | - |
Change in Working Capital | 22.16 | -64.99 | -10.68 | 1.47 | -4.69 |